Clinical Trial Update: AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating an anti-platelet strategy after left atrial appendage closure in atrial fibrillation patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Appendage Closure

Drugs mentioned

• Antiplatelet therapy strategy (unspecified)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Atrial Fibrillation, Atrial Appendage | Phase 4 | Status: UNKNOWN